BPC-157
Proper Handling
- Reconstitute with Bacteriostatic Water
- Specifications: Lyophilized powder in 3 mL vial. Purity (>99%) meets or exceeds U.S. Pharmacopeia (USP) regulations.
- Storage: In lyophilized form, the peptide is stable for 3 years. Protect from light. Refrigerate and use within 4-6 weeks after opening or reconstituting.
Need to speak with a clinician?
Schedule a wellness consultation with a practitioner specialized in peptide therapy, who will determine the best plan for you.
BPC-157 (Body Protection Compound) is a popular peptide providing anti-inflammatory effects & has been shown to help improve connective tissue injuries – such an ligament tears, tendon sprains, and joint injuries. Its efficiency lies in its potential to accelerate the regeneration of tissues and stimulate angiogenesis, the process of new blood vessel formation.
In addition to its wound healing properties, BPC-157 is noted for its protective qualities. It has been shown to guard organs, prevent stomach ulcers, and reduce discomfort from injuries.
CAS Number 137525-51-0
PubChem CID 137525-51-0
Molecular Weight 1419.5 g/mol
Molecular Formula C62H98N16O22
Synonyms PL 14736, PL-10, Bepecin, UNII-8ED8NXK95P, BPC-15, CHEMBL4297358, EX-A4283, MFCD06407962
Storage (Lyophilized)
At 39 Fahrenheit: 2 years
At -4 Fahrenheit: 3 years
This product is sold as a pure compound for research purposes only. This product comes in the form of lyophilized powder and must be reconstituted with bacteriostatic water prior to use. Please refer to our terms and conditions prior to purchase.
Safety Information: Keep this product out of the reach of children. This material has limited research available about it and may result in adverse effects if improperly handled or consumed. This product is not a dietary supplement, but a pure substance, sold as a raw material. We attest exclusively to the quality, purity and description of the materials we provide. This product is for use and handling only by persons with the knowledge and equipment to safely handle this material. You agree to indemnify us for any adverse effects that may arise from improper handling and/or consumption of this product.
The articles and information on products that may be found on this website are provided exclusively for the purposes of providing information and education. These items are not pharmaceuticals or medications, and the Food and Drug Administration has not given permission for the treatment or prevention of any disease, medical condition, or ailment using them.
- Chang, Chung-Hsun et al. “The promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth, cell survival, and cell migration.” Journal of applied physiology (Bethesda, Md. : 1985) vol. 110,3 (2011): 774-80. doi:10.1152/japplphysiol.00945.2010. https://pubmed.ncbi.nlm.nih.gov/21030672/
- J.I. Farrell. Contributions to The Physiology of Gastric Secretion. 01 Jul 1928. https://doi.org/10.1152/ajplegacy.1928.85.3.685
- Sikiric, Predrag et al. “Brain-gut Axis and Pentadecapeptide BPC 157: Theoretical and Practical Implications.” Current neuropharmacology vol. 14,8 (2016): 857-865. doi:10.2174/1570159x13666160502153022. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5333585/#r1
- Ormsbee, H S 3rd, and J D Fondacaro. “Action of serotonin on the gastrointestinal tract.” Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.) vol. 178,3 (1985): 333-8. doi:10.3181/00379727-178-42016. https://pubmed.ncbi.nlm.nih.gov/3919396/
- Krivic, A., Majerovic, M., Jelic, I. et al. Modulation of early functional recovery of Achilles tendon to bone unit after transection by BPC 157 and methylprednisolone. Inflamm. res. 57, 205–210 (2008). https://doi.org/10.1007/s00011-007-7056-8
- S Seiwerth, et al. “BPC 157's effect on healing.” Journal of physiology, Paris vol. 91,3-5 (1997): 173-8. doi:10.1016/s0928-4257(97)89480-6. https://pubmed.ncbi.nlm.nih.gov/9403790/
- Seiwerth, Sven et al. “BPC 157 and Standard Angiogenic Growth Factors. Gastrointestinal Tract Healing, Lessons from Tendon, Ligament, Muscle and Bone Healing.” Current pharmaceutical design vol. 24,18 (2018): 1972-1989. doi:10.2174/1381612824666180712110447. https://pubmed.ncbi.nlm.nih.gov/29998800/
- “The pharmacological properties of the novel peptide BPC 157 (PL-10).” Inflammo-pharmacology vol. 7,1 (1999): 1-14. doi:10.1007/s10787-999-0022-z. https://pubmed.ncbi.nlm.nih.gov/17657443/
- Pevec D, Novinscak T, Brcic L, Sipos K, Jukic I, Staresinic M, Mise S, Brcic I, Kolenc D, Klicek R, Banic T, Sever M, Kocijan A, Berkopic L, Radic B, Buljat G, Anic T, Zoricic I, Bojanic I, Seiwerth S, Sikiric P. Impact of pentadecapeptide BPC 157 on muscle healing impaired by systemic corticosteroid application. Med Sci Monit. 2010 Mar;16(3):BR81-88. PMID: 20190676. https://pubmed.ncbi.nlm.nih.gov/20190676/
- Jelovac, N et al. “A novel pentadecapeptide, BPC 157, blocks the stereotypy produced acutely by amphetamine and the development of haloperidol-induced supersensitivity to amphetamine.” Biological psychiatry vol. 43,7 (1998): 511-9. doi:10.1016/s0006-3223(97)00277-1. https://pubmed.ncbi.nlm.nih.gov/9547930/
- Gwyer, D., Wragg, N.M. & Wilson, S.L. Gastric pentadecapeptide body protection compound BPC 157 and its role in accelerating musculoskeletal soft tissue healing. Cell Tissue Res 377, 153–159 (2019). https://doi.org/10.1007/s00441-019-03016-8
- Veljaca, Marija et al, The development of PL 14736 for treatment of inflammatory bowel disease, Advanced in GI pharmacology, 2002 O-32. https://www.bib.irb.hr/192824
- Phase I clinical trial in healthy volunteers to study safety and pharmacokinetics of BPC-157, a pentadecapeptide from gastric source. https://clinicaltrials.gov/ct2/show/NCT02637284?
Frequently Asked Questions
BPC-157
-
BPC-157 (Body Protection Compound) is a very popular peptide that may provide anti-inflammatory effects & has been shown to help improve connective tissue injuries – such an ligament tears, tendon sprains, and joint injuries. BPC may decrease inflammation – helping alleviate pain.
The peptide BPC-157 comes in capsule and injectable forms.
-
BPC-157 is known for its anti-inflammatory effects and its ability to improve connective tissue injuries like ligament tears, tendon sprains, and joint injuries. It may aid in pain relief and healing digestive disorders. BPC-157 has been seen to have a host of health benefits.
-
BPC-157 is an injectable peptide administered subcutaneously through the fat. The most fatty parts of the body are the abdomen, side or back of upper arms, and front of thighs.
BPC-157 is for research purposes only, unless prescribed by a licensed physician. Schedule a wellness consultation to determine the best plan for your health and wellness goals.
-
BPC-157 is not approved by the FDA for human consumption. The only exceptions are for researchers and doctors who can purchase or prescribe BPC-157 under certain conditions.
Schedule a wellness consultation or talk to a specialist to determine the best plan for your health.
-
BPC-157 is commonly injected subcutaneously, making its use at risk for local redness, irritation, itching and swelling of the injection site.
it is important to consult with a medical professional prior to starting BPC-157.
Remember, everyone reacts differently to substances like BPC-157 due to individual physiological differences such as metabolism rate and overall health status. Talk to your healthcare provider about any side effect that bothers you or doesn’t go away. Tell your doctor if you have any side effects.
-
We're happy to help answer questions you may have, or refer you to a licensed healthcare professional for medical advice. Email us at care@somapeptides.com or schedule a telehealth appointment.
Your body, your journey.
Millions of people want to know how peptide therapy can help achieve achieve optimal health and performance.
Speak with specialists in peptide therapy about reconstituting lyophilized peptides, proper handling and storage, and other questions you may have.